...
首页> 外文期刊>Stem Cell Reports >A Multiwell Cardiac μGMEA Platform for Action Potential Recordings from Human iPSC-Derived Cardiomyocyte Constructs
【24h】

A Multiwell Cardiac μGMEA Platform for Action Potential Recordings from Human iPSC-Derived Cardiomyocyte Constructs

机译:从人iPSC衍生的心肌细胞构建物的动作电位记录的多孔心脏μGMEA平台

获取原文
           

摘要

Summary Multielectrode array (MEA) technology has been extensively used for field potential recordings from excitable cells. However, its application for action potential (AP) measurements has not been harnessed. Here, we report a novel platform for high-resolution intracellular AP recordings from induced pluripotent stem cell-cardiomyocyte constructs derived from human cardiac fibroblasts. To gain intracellular access, micro-gold MEAs were used to electroporate multiple constructs simultaneously. High-throughput AP measurements were obtained from 41 multicellular constructs. Repeated electroporations of the same cells did not affect the signal stability. Our model has the capability to distinguish subtle differences in AP morphology to characterize the network profile. Furthermore, we confirm the reliability of the system by recapitulating known drug-induced physiological and arrhythmogenic responses. Overall, the model provides a unique cardio-electronic interface for non-invasive measurements of AP dynamics for drug screening and disease modeling. This technology opens the door for identifying novel cardio-factors to enhance electrophysiological maturation.
机译:小结多电极阵列(MEA)技术已广泛用于可激发细胞的场电势记录。但是,尚未利用其在动作电位(AP)测量中的应用。在这里,我们报告了一个新的平台,用于高分辨率细胞内AP记录,该记录来自于人心脏成纤维细胞诱导的多能干细胞-心肌细胞构建体。为了获得细胞内通路,微金MEA用于同时电穿孔多个构建体。高通量AP测量是从41个多细胞构建体获得的。相同细胞的重复电穿孔不影响信号稳定性。我们的模型能够区分AP形态中的细微差异,以表征网络配置文件。此外,我们通过概括已知的药物诱导的生理和心律失常反应来确认系统的可靠性。总体而言,该模型为无创测量AP动态提供了独特的心电界面,用于药物筛选和疾病建模。这项技术为识别新的心脏因素打开了大门,以增强电生理学的成熟度。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号